Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
PaperCitations, authors & open-access status
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 573 citations, 2009 year and green oa status.
573
Citations
2009
Year
green
OA Status